CME (CME) insider buying
15 open-market purchases of CME by CME's executives and directors since September 2025, worth $224,221 in total, from SEC Form 4 filings.
The most recent: William R Shepard, Director bought $78,626 on September 25, 2026.
The biggest buyer over the period is William R Shepard (Director): 5 purchases, $224,221.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 5 | $78,626 |
| 2025 | 10 | $145,595 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| William R Shepard Director | 5 | $224,221 |
| Ro Khanna | 8 | $0 |
| Gilbert Ray Cisneros, Jr. | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Sep 25, 2026 | William R Shepard Director |
293 | $268.76 | $78,626 | Form 4 |
| Jan 29, 2026 | Ro Khanna |
0 | $289.83 | — | — |
| Jan 29, 2026 | Ro Khanna |
0 | $289.83 | — | — |
| Jan 9, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $262.45 | — | — |
| Jan 9, 2026 | Gilbert Ray Cisneros, Jr. |
0 | $262.45 | — | — |
| Dec 30, 2025 | William R Shepard |
11 | $278.37 | $3,062 | Form 4 |
| Dec 30, 2025 | William R Shepard |
251 | $278.37 | $69,871 | Form 4 |
| Nov 3, 2025 | Ro Khanna |
0 | $264.16 | — | — |
| Nov 3, 2025 | Ro Khanna |
0 | $264.16 | — | — |
| Oct 7, 2025 | Ro Khanna |
0 | $263.60 | — | — |
| Oct 7, 2025 | Ro Khanna |
0 | $263.60 | — | — |
| Sep 29, 2025 | Ro Khanna |
0 | $272.24 | — | — |
| Sep 29, 2025 | Ro Khanna |
0 | $272.24 | — | — |
| Sep 25, 2025 | William R Shepard |
12 | $265.22 | $3,183 | Form 4 |
| Sep 25, 2025 | William R Shepard |
262 | $265.19 | $69,480 | Form 4 |
Questions
Are CME insiders buying the stock?
15 open-market purchases of CME by CME's executives and directors since September 2025, worth $224,221 in total, from SEC Form 4 filings. The most recent: William R Shepard, Director bought $78,626 on September 25, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From CME's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.